+Compare
CRLBF
Stock ticker:
OTC
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
507.72M

CRLBF Cresco Labs Forecast, Technical & Fundamental Analysis

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for CRLBF with price predictions
08:00 PM EDT Jun 01, 2023

CRLBF in +20.77% Uptrend, advancing for three consecutive days on May 24, 2023

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CRLBF advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 23, 2023. You may want to consider a long position or call options on CRLBF as a result. In of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CRLBF just turned positive on May 23, 2023. Looking at past instances where CRLBF's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

CRLBF moved above its 50-day moving average on May 22, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CRLBF crossed bullishly above the 50-day moving average on May 24, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 137 cases where CRLBF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CRLBF moved out of overbought territory on May 26, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 48 cases where CRLBF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRLBF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRLBF broke above its upper Bollinger Band on May 24, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRLBF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.830) is normal, around the industry mean (42.346). P/E Ratio (0.000) is within average values for comparable stocks, (53.681). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.722). CRLBF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (0.611) is also within normal values, averaging (55.315).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRLBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Intra-Cellular Therapies (NASDAQ:ITCI), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.3B. The market cap for tickers in the group ranges from 246 to 79.43B. ZTS holds the highest valuation in this group at 79.43B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 25%. INLB experienced the highest price growth at 83%, while ABTI experienced the biggest fall at -59%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -98%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 72
Price Growth Rating: 53
SMR Rating: 85
Profit Risk Rating: 93
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

CRLBF is expected to report earnings to fall 45.81% to -3 cents per share on August 11

Cresco Labs CRLBF Stock Earnings Reports
Q2'23
Est.
$-0.03
Q1'23
Missed
by $0.02
Q4'22
Beat
by $0.04
Q3'22
Est.
$-0.01
Q2'22
Est.
$-0.02
The last earnings report on May 24 showed earnings per share of -6 cents, missing the estimate of -4 cents. With 303.10K shares outstanding, the current market capitalization sits at 507.72M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
400 W. Erie Street
Phone
+1 312 929-0993
Employees
3200
Web
https://www.crescolabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DTRUY15.670.39
+2.55%
DAIMLER TRUCK HLDG AG American Depositary Receipts - Sponsored
ACCYY6.760.07
+1.05%
Accor S A American Depositary Receipts - Sponsored (France)
NSRGY120.670.55
+0.46%
Nestle SA
ARGYF0.36N/A
-0.42%
AVANTI HELIUM Corp
VITFF6.42-0.26
-3.92%
Victoria Gold Corp.

Groups containing CRLBF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+0.60%
Pharmaceuticals: Other
(undefined stocks)
-1%
Poorly correlated
+1.33%
Pharmaceuticals
(undefined stocks)
-1%
Poorly correlated
+1.39%